069620 Stock Chart & Stats
$128300.00
$700.00(0.55%)
―
--
Day’s Range― - ―
52-Week Range$105,000.00 - $199,400.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
₩1.47T
Enterprise Value$2.70M
Total Cash (Recent Filing)₩168.03B
Total Debt (Recent Filing)₩900.43B
Price to Earnings (P/E)7.3
Beta0.17
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)17370.62
Shares Outstanding11,586,575
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)1.98
Price to Sales (P/S)1.27
P/FCF Ratio-47.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)13,887.66
Revenue Forecast (FY)₩1.56T
069620 FAQ
What was Daewoong Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Daewoong Pharmaceutical Co., Ltd. lowest stock price was $105000.00 and its highest was $199400.00 in the past 12 months.
What is Daewoong Pharmaceutical Co., Ltd.’s market cap?
Daewoong Pharmaceutical Co., Ltd.’s market cap is ₩1.47T.
When is Daewoong Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Daewoong Pharmaceutical Co., Ltd.’s upcoming earnings report date is Aug 18, 2026 which is in 20 days.
How were Daewoong Pharmaceutical Co., Ltd.’s earnings last quarter?
Daewoong Pharmaceutical Co., Ltd. released its earnings results on May 15, 2026. The company reported $2251.034 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Daewoong Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Daewoong Pharmaceutical Co., Ltd.’s price is currently Undervalued.
Does Daewoong Pharmaceutical Co., Ltd. pay dividends?
Daewoong Pharmaceutical Co., Ltd. does not currently pay dividends.
What is Daewoong Pharmaceutical Co., Ltd.’s EPS estimate?
Daewoong Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Daewoong Pharmaceutical Co., Ltd. have?
Daewoong Pharmaceutical Co., Ltd. has 11,586,575 shares outstanding.
What happened to Daewoong Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Daewoong Pharmaceutical Co., Ltd. reported an EPS of $2251.034 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.001%.
Which hedge fund is a major shareholder of Daewoong Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in KR:069620
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Daewoong Pharmaceutical Co., Ltd.
Established in 1945 and headquartered in Seoul, South Korea, Daewoong Pharmaceutical Co., Ltd. is a global entity dedicated to the research, production, and international distribution of a diverse range of pharmaceutical products. Its extensive portfolio provides therapeutic solutions across numerous health disciplines, including treatments for central nervous system disorders, endocrine conditions, musculoskeletal ailments, nephrological issues, oncology, cardiovascular diseases, gastrointestinal complaints, and metabolic dysfunctions. The company further offers products addressing viral infections, pain relief, antacids, digestive problems, wound care, and nutritional supplements such as iron and multivitamins. Complementing its pharmaceutical offerings, Daewoong also supplies medical devices, notably COVID-19 PCR and IgG/IgM RDT diagnostic kits, along with viral transport media.
JW Pharmaceutical Corporation
―
Chong Kun Dang Holdings Co., Ltd.
―
Bukwang Pharmaceutical Co., Ltd.
―
Celltrion Pharm Inc.
―
Dong-A ST Co., Ltd.
―